Logo image of JGGC

Jaguar Global Growth Corporation I (JGGC) Stock Fundamental Analysis

NASDAQ:JGGC - Nasdaq - KYG5S11A1066 - Common Stock - Currency: USD

1.7  -5.39 (-76.02%)

After market: 1.98 +0.28 (+16.47%)

Fundamental Rating

2

Overall JGGC gets a fundamental rating of 2 out of 10. We evaluated JGGC against 0 industry peers in the Unkown industry. The financial health of JGGC is average, but there are quite some concerns on its profitability. JGGC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

JGGC had positive earnings in the past year.
In the past year JGGC has reported a negative cash flow from operations.
JGGC Yearly Net Income VS EBIT VS OCF VS FCFJGGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 0 2M -2M 4M

1.2 Ratios

Industry RankSector Rank
ROA 2.59%
ROE 2.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JGGC Yearly ROA, ROE, ROICJGGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 0 50 100 150 200 250

1.3 Margins

JGGC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JGGC Yearly Profit, Operating, Gross MarginsJGGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022

More info and screens

4

2. Health

2.1 Basic Checks

JGGC has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for JGGC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JGGC Yearly Shares OutstandingJGGC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M
JGGC Yearly Total Debt VS Total AssetsJGGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

JGGC has an Altman-Z score of 1.19. This is a bad value and indicates that JGGC is not financially healthy and even has some risk of bankruptcy.
JGGC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.19
ROIC/WACCN/A
WACCN/A
JGGC Yearly LT Debt VS Equity VS FCFJGGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

JGGC has a Current Ratio of 0.26. This is a bad value and indicates that JGGC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.26 indicates that JGGC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.26
Quick Ratio 0.26
JGGC Yearly Current Assets VS Current LiabilitesJGGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 200K 400K 600K 800K 1M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 368.77% over the past year.
EPS 1Y (TTM)368.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JGGC Yearly Revenue VS EstimatesJGGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022
JGGC Yearly EPS VS EstimatesJGGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 8.50, the valuation of JGGC can be described as very reasonable.
The average S&P500 Price/Earnings ratio is at 29.62. JGGC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.5
Fwd PE N/A
JGGC Price Earnings VS Forward Price EarningsJGGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JGGC Per share dataJGGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

JGGC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Jaguar Global Growth Corporation I

NASDAQ:JGGC (11/15/2023, 8:00:02 PM)

After market: 1.98 +0.28 (+16.47%)

1.7

-5.39 (-76.02%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap30.16M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.13
P/tB 0.13
EV/EBITDA N/A
EPS(TTM)0.2
EY11.76%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS12.84
TBVpS12.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.59%
ROE 2.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.26
Quick Ratio 0.26
Altman-Z 1.19
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)368.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%67.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1347.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13515.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13515.4%
OCF growth 3YN/A
OCF growth 5YN/A